Comparative Evaluation of CEUS and CECT in the Detection of Liver Metastases of Middle and Low Rectal Cancer Authors: Yaoli Liu, Haimei Lun, Xuanzhang Huang, JianYuan Huang, Shangyong Zhu Published: 2024 ABSTRACT AbstractObjectiveTo explore the imaging manifestations and clinical application value of contrast-enhanced ultrasound (CEUS) in liver metastases of middle and low rectal cancer by performing CEUS in patients. Additionally, we compared the results of CEUS with those of abdominal contrast-enhanced computed tomography (CECT) to assess the reliability of diagnosing liver metastases in patients with middle and low rectal cancer.MethodsHepatic CEUS was performed in 1095 patients with middle and low rectal cancer, and all patients underwent abdominal CECT examinations to determine the presence or absence of liver metastases. The results of both examinations were compared to evaluate the value of hepatic CEUS for detecting liver metastases in patients with middle and low rectal cancer.ResultsAmong 1095 patients with middle and low rectal cancer, 132 were diagnosed with liver metastases of middle and low rectal cancer. 130 cases of liver metastases of rectal cancer were identified using hepatic CEUS, whereas 126 cases were identified using abdominal CECT. The detection rates of hepatic CEUS and abdominal CECT for liver metastases of middle and low rectal cancer showed no statistically significant differences (P > 0.05). The Kappa value for the diagnosis of liver metastases of middle and low rectal cancer between hepatic CEUS and abdominal CECT was 0.974 (P < 0.001), indicating good consistency between the two imaging modalities in detecting liver metastases of middle and low rectal cancer.ConclusionHepatic CEUS can be used to diagnose liver metastases in middle and low rectal cancer, providing crucial imaging evidence for clinical treatment planning. It exhibited higher sensitivity than that of abdominal CECT in diagnosing liver metastases of middle and low rectal cancer, enabling the identification of higher number of liver metastases of middle and low rectal cancer cases.Keywords: middle and low rectal cancer, hepatic CEUS, abdominal CECT, liver metastases Introduction Rectal cancer is a common malignant tumor of the digestive system that occurs more frequently in middle-aged and older adults, with the highest incidence occurring between the ages of 40–70 years. Changes in dietary structure and lifestyle habits have led to an increasing trend in the incidence and mortality of rectal cancer in recent years, significantly affecting the quality of life and survival. During its growth, rectal cancer can metastasize and spread to other adjacent tissues and distant organs through the lymphatic, blood circulation, and direct extension pathways. Liver metastases is the most common type of hematogenous metastasis in rectal cancer. When liver metastases occur in patients with rectal cancer, the treatment plan depends on the condition of the metastatic lesions to improve the patient’s quality of life and survival. Complete removal of liver metastatic lesions can greatly improve the 5-year survival rate of patients, reaching 30–57%.1–4 Abdominal CT and MRI are commonly used in clinical practice to assess liver metastases in patients with rectal cancer.5 With the continuous improvement in ultrasound contrast agents, CEUS is increasingly used in clinical settings and has shown good efficacy in diagnosing liver metastases in rectal cancer. It is suitable for determining the presence of liver metastases in patients with rectal cancer. Hepatic CEUS not only evaluates the presence of liver metastases in patients with rectal cancer but also provides quantitative analysis of contrast enhancement, offering relatively accurate imaging information on hepatic tissue microperfusion for assessing the effectiveness of chemotherapy in metastatic tumors.6 This study explored the diagnostic efficacy of hepatic CEUS in liver metastases of middle and low rectal cancer through a comparison of hepatic CEUS and abdominal CECT in the detection of liver metastatic lesions in patients with middle and low rectal cancer. We hope this study offers insights into novel imaging data for the diagnosis of liver metastatic lesions in middle and low rectal cancers and the formulation of treatment plans for rectal cancer. Materials and Methods Study Participants A total of 1095 patients with middle and low rectal cancer were recruited from the First Affiliated Hospital of Guangxi Medical University. Middle and low rectal cancer refer to rectal cancer within 5–10 cm of the anal margin. All patients underwent hepatic CEUS. Among them, 709 were male and 386 were female, with an age range of 20 to 89 years and an average age of 57.80±11.68 years. The inclusion criteria were as follows: (1) complete clinical data; (2) hepatic CEUS and abdominal CECT examination performed before treatment, with CEUS conducted before CECT; (3) underwent rectal tumor resection surgery with postoperative pathological confirmation of rectal cancer; and (4) no prior chemotherapy or radiotherapy before surgery. The exclusion criteria were as follows: (1) concurrent malignant tumors with possible liver metastases, (2) potential allergy to contrast agents used in ultrasonography, (3) severe cardiovascular or cerebrovascular diseases or significant liver or kidney dysfunction that might hinder examination and surgery, and (4) unconfirmed liver metastases of rectal cancer. The study was approved by The Medical Ethics Committee of First Affiliated Hospital of Guangxi Medical University, and there were no ethical issues. Patients and their families were informed of the risks and potential accidents related to hepatic CEUS, and relevant documents were signed and archived. Instruments and Methods Hepatic CEUS Examination Equipment, Materials, and Methods A TOSHIBA Aplio 500 multifunctional color Doppler ultrasound diagnostic instrument (TOSHIBA Group, Japan) with a convex array probe operating at a frequency of 6–8 MHz was used. SonoVue (Bracco Suisse SA, Switzerland) was used as the contrast agent for ultrasonography. Hepatic CEUS was performed in all patients with middle and low rectal cancer. For focal lesions identified during two-dimensional ultrasound examination, CEUS was used to observe the enhancement characteristics, time, level, and morphology; changes in the discovered focal lesions; and the infiltration of adjacent tissues to determine the nature of the lesions. For patients in whom focal lesions were not detected in the two-dimensional ultrasound examination, we performed a comprehensive evaluation of the entire liver in both the arterial and portal venous phases using CEUS. If lesions with abnormal enhancement or regression were identified, a second CEUS examination targeting the lesions was performed after a 15-min rest. Upper Abdominal CECT Examination Equipment, Materials, and Methods CECT was performed using a Siemens SOMATOM Definition Flash CT scanner (Siemens, Germany) with 128 rows. Iopromide was the contrast agent used for CT. The scanning range for abdominal CECT was the upper abdomen, from the diaphragmatic apex to the lower margin of the liver, with plain scans, followed by enhanced scans. Image Analysis Hepatic CEUS Image Analysis Hepatic CEUS images were jointly reviewed by two ultrasound physicians with more than 5 years of experience in CEUS imaging. The CEUS process was divided into three phases: 5–30 s for the arterial phase, 31–120 s for the portal venous phase, and 121–360 s for the delayed phase. Abdominal CECT Image Analysis Abdominal CECT images were jointly interpreted by two radiologists with more than 5 years of experience in CECT images. The enhancement patterns and degrees during the arterial and portal venous phases on CECT were judged based on the contrast with the surrounding liver parenchyma density of the corresponding lesion. Statistical Analysis Statistical analysis of the study data was performed using the SPSS software (version 23.0; IBM, Armonk, NY, USA). Count data are expressed as rates or composition ratios, and the chi-square test was used with P<0.05 indicating statistical significance. A consistency analysis between CEUS and CECT diagnoses of liver metastases of rectal cancer was conducted using the Kappa index. A higher Kappa value indicated better consistency, with Kappa≥0.75 considered good consistency, 0.40